GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (FRA:EWL) » Definitions » 3-Year EBITDA Growth Rate

Edwards Lifesciences (FRA:EWL) 3-Year EBITDA Growth Rate : 20.60% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Edwards Lifesciences 3-Year EBITDA Growth Rate?

Edwards Lifesciences's EBITDA per Share for the three months ended in Mar. 2024 was €0.73.

During the past 12 months, Edwards Lifesciences's average EBITDA Per Share Growth Rate was -5.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 20.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 17.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Edwards Lifesciences was 57.80% per year. The lowest was -24.10% per year. And the median was 14.80% per year.

Competitive Comparison of Edwards Lifesciences's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Edwards Lifesciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Edwards Lifesciences's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's 3-Year EBITDA Growth Rate falls into.


Edwards Lifesciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Edwards Lifesciences  (FRA:EWL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Edwards Lifesciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (FRA:EWL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (FRA:EWL) » Definitions » 3-Year EBITDA Growth Rate
Comparable Companies
DXCM ZBH ALGN STE SWAV BRKR PODD PEN BIO MASI ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil EWLS:Austria
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.